We are live on ! Find out more
GS

GTS Securities Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.76%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+21.76%
3 Year Est. Return
+68.93%
5 Year Est. Return
10 Year Est. Return
AUM
$46B
AUM Growth
-$945M
Cap. Flow
-$2.64B
Cap. Flow %
-5.74%
Top 10 Hldgs %
38.54%
Holding
4,570
New
696
Increased
1,653
Reduced
1,646
Closed
543

Sector Composition

Rank Sector Weight
1 Technology 2.2%
2 Consumer Discretionary 1.38%
3 Communication Services 0.71%
4 Healthcare 0.57%
5 Financials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FL
1526
CALL
DELISTED
Foot Locker
FL
$2.15M ﹤0.01%
83,100
+4,900
+6% +$135K
BE icon
1527
CALL
Bloom Energy
BE
$70.8B
$2.14M ﹤0.01%
202,800
+68,400
+51% +$811K
EQNR icon
1528
Equinor
EQNR
$93B
$2.14M ﹤0.01%
84,518
-13,729
-14% -$362K
ARKG icon
1529
ARK Genomic Revolution ETF
ARKG
$1.63B
$2.14M ﹤0.01%
83,556
-233,368
-74% -$5.94M
IVV icon
1530
PUT
iShares Core S&P 500 ETF
IVV
$896B
$2.13M ﹤0.01%
3,700
-400
-10% -$222K
CAR icon
1531
CALL
Avis
CAR
$4.82B
$2.13M ﹤0.01%
24,300
-4,200
-15% -$379K
AAL icon
1532
CALL
American Airlines Group
AAL
$10.8B
$2.13M ﹤0.01%
189,300
-255,700
-57% -$2.7M
ADI icon
1533
Analog Devices
ADI
$185B
$2.13M ﹤0.01%
9,242
-21,432
-70% -$4.83M
VLUE icon
1534
iShares MSCI USA Value Factor ETF
VLUE
$9.4B
$2.13M ﹤0.01%
19,502
+10,363
+113% +$1.09M
UL icon
1535
Unilever
UL
$137B
$2.12M ﹤0.01%
+29,073
New +$2.01M
SMAR
1536
DELISTED
Smartsheet Inc.
SMAR
$2.12M ﹤0.01%
+38,352
New +$1.86M
SHUS icon
1537
Syntax Stratified US Total Market Hedged ETF
SHUS
$25.2M
$2.12M ﹤0.01%
49,061
+24,012
+96% +$1M
NBIX icon
1538
PUT
Neurocrine Biosciences
NBIX
$16.4B
$2.12M ﹤0.01%
18,400
+8,500
+86% +$1.17M
BCS icon
1539
Barclays
BCS
$95.3B
$2.12M ﹤0.01%
174,332
+40,976
+31% +$480K
FE icon
1540
CALL
FirstEnergy
FE
$27.5B
$2.12M ﹤0.01%
47,700
-16,600
-26% -$699K
MCO icon
1541
Moody's
MCO
$82.2B
$2.11M ﹤0.01%
4,449
-2,125
-32% -$985K
ORCL icon
1542
Oracle
ORCL
$415B
$2.11M ﹤0.01%
12,366
-1,963
-14% -$284K
TEVA icon
1543
PUT
Teva Pharmaceuticals
TEVA
$40.2B
$2.11M ﹤0.01%
116,900
-18,700
-14% -$327K
CP icon
1544
PUT
Canadian Pacific Kansas City
CP
$79.4B
$2.1M ﹤0.01%
24,600
-6,000
-20% -$493K
IWO icon
1545
CALL
iShares Russell 2000 Growth ETF
IWO
$14.9B
$2.1M ﹤0.01%
7,400
-27,000
-78% -$7.4M
EXP icon
1546
PUT
Eagle Materials
EXP
$6.51B
$2.1M ﹤0.01%
7,300
+300
+4% +$75K
HYG icon
1547
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.1M ﹤0.01%
26,100
-51,600
-66% -$4.06M
GME icon
1548
CALL
GameStop
GME
$8.55B
$2.1M ﹤0.01%
91,400
-19,000
-17% -$434K
SHAK icon
1549
PUT
Shake Shack
SHAK
$2.85B
$2.1M ﹤0.01%
20,300
-300
-1% -$28.9K
BNTX icon
1550
CALL
BioNTech
BNTX
$22.6B
$2.09M ﹤0.01%
17,600
+7,600
+76% +$699K

Similar funds

GTS Securities's Q3 2024 Portfolio in Review

As of Q3 2024, GTS Securities held 4,570 positions worth $46B, down 2% from $46.9B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

GTS Securities withdrew a net $2.64B in Q3 2024, closing 543 positions and reducing 1,646 holdings. Its most notable exit was ProShares UltraPro Short QQQ, an estimated $33.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, down from 2.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, GTS Securities opened a new position in ProShares UltraPro QQQ worth $23.2M.

  • GTS Securities's largest Q3 2024 buy was ProShares UltraPro QQQ: 640,308 shares worth $23.2M.
  • GTS Securities added most to Microsoft in Q3 2024, an estimated $112M increase.
  • GTS Securities's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $141M.
  • GTS Securities fully exited ProShares UltraPro Short QQQ in Q3 2024, selling an estimated $33.4M.
  • GTS Securities's ten largest holdings make up 39% of its $46B portfolio in Q3 2024.
  • GTS Securities opened 696 new positions and closed 543 in Q3 2024.
  • GTS Securities's portfolio value fell 2% quarter-over-quarter to $46B.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.